dimecres, 1 d’abril del 2015

Diabetes: Asante Solutions withdraws IPO




Asante Solutions withdraws its plans for the initial public offering it hoped would raise $49 million for its Snap modular insulin pump.






Asante Solutions withdrew its plans for an initial public offering it had hoped would bring in $49 million for its Snap modular insulin pump.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ak8ETY

Cap comentari:

Publica un comentari a l'entrada